consistently colocalized with PSD-95 in neurons, even
Since all known members of the GKAP family (GKAP/ binding to PSD-95, which is mediated by the N-terminal region of GKAP . In cells triply trans-SAPAP1-4) terminate with the same four amino acids (-QTRL) (Takeuchi et al., 1997) , each member can prefected with mutant GKAP1a(L666A) ϩ Shank1 ϩ PSD-95, Shank was not coprecipitated by GKAP antibodies, sumably interact with Shank. However, it is noteworthy that splice variants of GKAP1 exist with alternative C even though the cognate antigen GKAP was efficiently brought down ( Figure 3A , lane 8). Moreover, PSD-95 was termini, an example being GKAP1b (termed hGKAP in . GKAP1b ends in the sequence GQSK* not significantly coprecipitated with Shank antibodies, though its coimmunoprecipitation with GKAP remained and does not interact with Shank ( Figure 1B) . robust ( Figure 3A , compare lanes 7 and 8). This experiment demonstrates that GKAP1a and Shank1 can asso-
GKAP Binds Shank and Recruits Shank to PSD-95 Clusters in Heterologous Cells
ciate in heterologous cells via a mechanism dependent on the C terminus of GKAP1a. Furthermore, GKAP1a To demonstrate biochemical association of GKAP and Shank proteins in a mammalian cell context, we percan mediate the association of PSD-95 with Shank1. These findings are consistent with the formation of a formed coimmunoprecipitation from transfected COS7 cells ( Figure 3A) . Since GKAP is known to associate with ternary complex in which GKAP uses its N-terminal region to bind to PSD-95 and its C terminus to bind to PSD-95 (Kim et al., 1997), we included PSD-95 in these experiments. In cells triply transfected with wild-type Shank. Shank1 and GKAP1a also coimmunoprecipitate in the absence of PSD-95 (data not shown). GKAP1a ϩ Shank1 ϩ PSD-95, both GKAP and Shank could be coimmunoprecipitated by antibodies specific
We have previously shown that PSD-95 and its relatives can cause the clustering of Shaker K ϩ channels for either protein, but not by control (nonimmune IgG) antibodies ( Figure 3A, lanes 1-4) . GKAP antibodies also and NMDA receptors when coexpressed in COS7 cells (Kim et al., , 1996 and that GKAP can be recruited coprecipitated PSD-95, as expected. Antibodies to Shank brought down a significant amount of PSD-95 in into these clusters by binding to PSD-95 . To test whether GKAP might recruit Shank to addition to GKAP, implying the formation of a ternary complex containing Shank/GKAP/PSD-95 (Figure 3A, PSD-95 clusters, we looked for coclustering in COS7 cells triply transfected with Shank1 ϩ PSD-95 ϩ lane 3). We reasoned that a C-terminal point mutation in GKAP1a (changing the last amino acid L666→A) would GKAP1a or with Shank1 ϩ PSD-95 ϩ GKAP1b (the GKAP splice variant terminating in -GQSK* instead of -QTRL*) abolish interaction with Shank but not interfere with , 1995, 1996) . In cells transfected with Shank1 ϩ PSD-95 ϩ GKAP1b, however, Shank immunoreactivity GST pulldown experiments from rat brain extracts were performed to verify biochemical association of Shank remains diffuse and does not colocalize with PSD-95 ( Figure 3C ). PSD-95 and GKAP form coaggregates in and GKAP. Sepharose beads charged with GST fusion protein of Shank1(SH3-PDZ) precipitated a large fracthese cells ( Figure 3C , right), as they do even in the absence of Shank (data not shown). Thus, GKAP1a, but tion of GKAP present in the offered extract ( Figure 4A ). In addition to GKAP, GST-Shank1(SH3-PDZ) brought not GKAP1b, can mediate the coclustering of Shank1 with PSD-95 in heterologous cells. This is consistent down PSD-95, chapsyn-110/PSD-93, and NR1 (a subunit of NMDA receptors). These pulldowns were spewith GKAP1a recruiting Shank1 via its specific C-terminal PDZ-binding sequence. Shank1 and GKAP1a do not cific, since SAP97, synaptophysin, and glutamic acid protein pulled down Shank, it did not pull down GKAP specifically pulled down Shank proteins from brain ex-( Figure 4A ). This is presumably because GST-GKAP1a(C-term) can only bind to Shank with an unoccupied tract ( Figure 4A, bottom panel) Figure 4B ). biochemical purification of rat brain PSDs ( Figure 6A ).
Shank antibodies immunoprecipitated Shank proteins
The heterogeneous set of Shank polypeptides was with high efficiency, and in addition they coprecipitated highly enriched in PSD preparations and was resistant significant amounts of GKAP and PSD-95 and chapsynto extraction by Triton X-100 and sarkosyl detergents. cell extracts, cells were washed and pelleted followed by resuspenusing the L40 yeast strain harboring HIS3 and ␤-gal as reporter sion in (in mM): 50 Tris (pH 7.4), 75 NaCl, 2.5 EGTA, 2.5 EDTA, 1% genes. GKAP1a residues 591-666 were subcloned into pBHA (LexA SDS, followed by 4-fold dilution in 1% Tx-100, 50 Tris (pH 7.4), 150 fusion vector) and used to screen ‫5.1ف‬ ϫ 10 6 clones from rat and NaCl, 2.5 EGTA, 2.5 EDTA plus protease inhibitors and 1 hr 16,000 ϫ human cDNA libraries constructed in pGAD10 (GAL4 activation dog centrifugation. Supernatants were incubated with 2 g of control main vector, Clontech). For analysis of specificity and binding dononimmune IgG, Shank 56/e, or a 1:1 mixture of GKAP N1564 and mains, desired cDNA segments were amplified by PCR with specific C9589 antibodies. Extracts of forebrain synaptosomes for immunoprimers and subcloned into pBHA or pGAD10. Two-hybrid conprecipitation were prepared using either SDS (more efficient for structs of Kv1.4 and PSD-95 have been described .
GKAP coimmunoprecipitation with Shank) or DOC (more efficient Shank1(SH3-PDZ) contains residues 469-691, and Shank1(PDZ) for Shank coimmunoprecipitation with GKAP). Extraction of forecontains residues 684-691 of Shank1a. Mutations of GKAP C-termibrain P2 in 1% DOC was performed as described (Dunah et al., nal residues were generated by PCR of GKAP1a (residues 591-666) 1998) followed by dialysis overnight into 0.1% Tx-100, 50 mM Tris using antisense primers containing specific nucleotide substitu-(pH 7.4). Concurrently, 5 g each antibody was preincubated overtions. night with 10 l protein A-sepharose. After clearing at 100,000 ϫ g for 1 hr, dialyzed extract (50 g protein) was incubated with antiAntibodies body-protein A in 100 l 0.1% Tx-100, 50 mM Tris, (pH 7.4) for 2 Shank antibodies were raised in rabbits against a GST fusion of hr at 4ЊC. Precipitates were washed four times with 1 ml of incubation Shank1a residues 469-691 and affinity purified using a thioredoxin buffer. For antigen competition controls, TRX-gk2.1 (see Kim et al., fusion of same region (these are termed Shank 56/8 antibodies). In 1997) or TRX-GKAP1a(C-term) at 100 g/ml concentration were some experiments, the IgG fraction purified by protein A-sepharose present during all antibody incubation steps. For SDS extraction, was used (these are termed Shank 56/e antibodies). Identical bands the 1% Tx-100-insoluble pellet from P2 was solubilized in 1% SDS were seen on rat brain immunoblots using both antibody preparaplus 5 mM ATP, 0.05% ␤-mercaptoethanol, followed by 4-fold dilutions, and preincubation with a thioredoxin fusion of Shank1 (resition in 1% Tx-100 quenching buffer plus 5 mM ATP, 0.05% ␤-merdues 469-591) abolished the signal of both antibodies (data not captoethanol. After centrifugation at 100,000 ϫ g for 1 hr, soluble shown). In addition, an independent peptide antibody raised against extract (300 g protein) was incubated with 2.5 g of control nonima nonoverlapping region of Shank1 (residues 422-440) detected mune IgG, Shank 56/e, or GKAP N1564 antibodies. After 2 hr incubaidentical bands on rat brain immunoblots (E. K., S. N., and M. S., tion at 4ЊC, 10 l protein A-sepharose beads was added for 2 hr. unpublished data). The following antibodies have been described: Pellets were washed four times in Tx-100 quenching buffer. Deteranti-GKAP N1564 and C9589 (Kim et 
